➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Baxter
McKesson
Express Scripts
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077150

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 077150 describes CILOSTAZOL, which is a drug marketed by Actavis Elizabeth, Apotex Inc, Breckenridge Pharm, Casi Pharms Inc, Chartwell Rx, Epic Pharma Llc, Hikma, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Pliva Hrvatska Doo, Slate, and Teva, and is included in sixteen NDAs. It is available from eight suppliers. Additional details are available on the CILOSTAZOL profile page.

The generic ingredient in CILOSTAZOL is cilostazol. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cilostazol profile page.
Summary for 077150
Tradename:CILOSTAZOL
Applicant:Epic Pharma Llc
Ingredient:cilostazol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Mar 11, 2005TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
McKinsey
Dow
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.